Genetic background of the T cell can influence T helper (Th) phenotype development, with some murine strains (e.g., B1O.D2) favoring Thl development and others (e.g., BALB/c) favoring Th2 development. Recently we found that B1O.D2 exhibit an intrinsically greater capacity to maintain interleukin 12 (IL-12) responsiveness under neutral conditions in vitro compared with BALB/c T cells, allowing for prolonged capacity to undergo IL-12-induced Thl development. To begin identification of the loci controlling this genetic effect, we used a T-cell antigen receptor-transgenic system for in vitro analysis of intercrosses between BALB/c and B1O.D2 mice and have identified a locus on murine chromosome 11 that controls the maintenance of IL-12 responsiveness, and therefore the subsequent Thl/Th2 response. This chromosomal region is syntenic with a locus on human chromosome 5q31.1 shown to be associated with elevated serum IgE levels, suggesting that genetic control of Thl/Th2 differentiation in mouse, and of atopy development in humans, may be expressed through similar mechanisms.
CD4+ T cells participate in immune responses by producing cytokines that regulate effector activities of cytolytic T cells, B cells, and macrophages. CD4+ T cells can acquire distinct highly polarized patterns of cytokine production. T helper type 1 (Thl) CD4+ T cells produce inflammatory cytokines such as interferon y (IFN-,y), lymphotoxin, and interleukin 2 (IL-2), whereas T helper type 2 (Th2) CD4+ T cells produce substantial IL-4, IL-5, and IL-10. The development of Thl or Th2 cells is regulated principally by certain cytokines, specifically IL-12 and IL-4, present during primary T-cell activation (1) (2) (3) (4) . While not all immune responses exhibit strongly polarized CD4+ T-cell development, Thl or Th2 cells often dominate during chronic pathological processes or in response to certain pathogens. For example, elimination of Listeria monocytogenes infection requires a Thl response (5) because activation of macrophages by IFN-,y is necessary for killing this intracellular organism. Accordingly, the immune system has developed specific mechanisms to ensure a Thl response. Listeriainfected macrophages produce IL-12, which directs Thl development of CD4+ T cells, a mechanism operative in all mouse strains examined.
In contrast, some responses involving Th phenotype development are genetically regulated. For example, genetic background influences development in humans of atopic immune responses (6) . Th2-derived cytokines, particularly IL-4 and IL-5, have been implicated in the pathogenesis of asthma and allergy (7) . Interestingly, certain phenotypic markers of asthma and atopy, specifically total serum IgE (8, 9) and airway hyper-reactivity (10) , have been linked genetically to a region on the long arm of human chromosome 5 containing a cluster of cytokine genes (e.g., IL-4, IL-3, IL-5) and other genes (interferon regulatory factor-1) that may influence Thl/Th2 development. The profound influence of genetics upon Thl/ Th2 immune responses is also exemplified by murine experimental Leishmania major infection. Elimination of this pathogen requires a host Thl response. This fails to occur in some murine genetic backgrounds, such as BALB/c, which generate a pathological Th2 response (11, 12) .
We recently analyzed the genetic control of Thl/Th2 development in a13-T-cell antigen receptor transgenic (TCR) CD4+ T cells in vitro (13, 14) . We began by crossing the DO11.10 af3-TCR transgenes into BALB/c and B1O.D2 strains to allow direct comparison of in vitro Th phenotype development of CD4+ T cells having identical TCR and antigen specificity but distinct genetic backgrounds. T cells from the B1O.D2 background maintained IL-12 responsiveness in culture (14) and exhibited a greater tendency for Thl development (13) compared with identically treated BALB/c T cells, which lost IL-12 responsiveness in culture and exhibited a Th2-like developmental response. In this report, we show that the difference in maintenance of IL-12 responsiveness, and subsequent Thl/Th2 development, is controlled by a single dominant genetic locus. Using simple sequence length polymorphism (SSLP) analysis (15, 16) of experimental backcrosses between these strains, we have mapped this locus to a region of mouse chromosome 11 containing a cluster of genes important for T-cell differentiation, including IL-4, IL-5, IL-3, and interferon regulatory factor-1. This region is syntenic with the homologous gene cluster on human chromosome 5 previously linked to several phenotypic markers of atopy (8) (9) (10) .
MATERIALS AND METHODS
Mice. BALB/c and BlO.D2/nSnJ female mice were purchased from Harlan-Sprague-Dawley and the The Jackson Laboratory, respectively. The DO11.10 mouse had been bred for more than 8 generations in the BALB/c background by mating TCR transgenes heterozygous male mice to female BALB/c mice and selecting transgenic progeny, as described (1) . Homozygous aJ3TCR (+/+) transgenic DO11.10 mice were then generated by sibling matings and subsequent testing (J.D.G., unpublished data). TCR heterozygous mice, from BALB/c female x TCR (+/+) DO11.10 male crosses, were used for experiments. All B1O.D2 female x TCR (+/+) (Fig. 1 ). Under neutral activation conditions (no added IL-4 or IL-12), T-cell genetic background significantly influences development, controlling "default" phenotype (13) and the maintenance of IL-12 responsiveness (14) . In assay I (Fig. 1 (Fig. 3) were examined by assay I. F1 T cells produced between 100 and 280 units/ml IFN-,y, whereas BALB/c T cells produced fewer than 25 units/ml (Fig. 3) . Among 18 BC1 mice, 10 maintained (140-400 units/ml IFN-,y), and 8 lost (<20 units/ml IFN-'y) (15, 16) . Consistent with the prediction of a single control locus, only one region, the middle of chromosome 11, showed significant association of homozygotes to the BALB/c phenotype, and heterozygotes to the F, phenotype ( Table 1 ). The marker DllMitlll (and linked markers; see Fig. 5 ) showed the strongest association in this analysis (P value = 0.0012). In contrast, no other regions showed association, with most P values exceeding 0.05. Additionally, this experiment allowed us to map the integration site of the DO11.10 transgenes (derived in this backcross from the BALB/c background; see Materials and Methods), through the observation of complete segregation distortion of markers on distal chromosome 18 to BALB/c homozygous genotypes (data not shown).
We repeated the above analysis in separate cohorts of BC1 mice using Assay II for Thl development (Fig. 1) , rather than immediate cytokine production, to assign independent phenotypes for IL-12 responsiveness (Fig. 4) . Purified BC1, F1, or BALB/c CD4+ T cells were activated for 1 week, washed, and restimulated (+5 units/ml IL-12), then washed and restimulated (no added IL-12). F1 T cells produced significantly higher levels of IFN-,y upon tertiary stimulation than did BALB/c T cells. From six independent experiments, the average IFN--y production by F1 T cells was 471 units/ml, (180-1067 units/ml), whereas that by BALB/c T cells was only 17 units/ml IFN--y (3-43 units/ml) (Fig. 4) 14 could not be classified (Fig. 4) .
We analyzed the 39 classified BC1 mice with 197 SSLP genetic markers covering the entire genome. Again, only one (Table 1) . Because both assay I and assay II independently established strong associations to markers in the middle of chromosome 11, we analyzed the combined data from all the cohorts (n = 72) observing a P value of 1.1 x 10-7 for marker DllMitlll (and linked markers) ( Table 1 ). This significance level clearly indicates the presence of a locus that influences T-cell phenotype response in these assays. Accordingly, we will refer to this locus as Tpml (T-cell phenotype modifier 1).
To better define the exact map position of Tpml, we analyzed the data using MAPMAKER (17) . the mouse genome (total autosomal length = 1558 cM), containing no isolated double crossovers to indicate genotyping errors. In comparing segregation of the phenotypes with the genotypic data, strong linkage of Tpml to individual markers on chromosome 11 was seen. The penetrance of the trait as measured by these assays is not 100%, because it was impossible to find a map position for Tpml without a double crossover. Consequently, we mapped Tpml using a modified version of MAPMAKER/QTL that optimizes for the penetrance of a phenotype in a particular genotypic class, and calculates the lod score at each position of the map for that optimized set of penetrances (see Materials and Methods). According to this analysis, the maximum likelihood position of Tpml is between DllMitlll (and associated markers) and DllMit274 (and associated markers) (Fig. 5) , supported by a lod score of 6.5. Overall, the penetrance of the trait (percentage of animals whose genotype at the locus is in concordance with its phenotype) is 83% at the DllMitlll-DllMit274 interval.
The incomplete penetrance of Tpml, when analyzed as a qualitative, single gene locus, suggested that other genes may be influencing the phenotype. Because we saw no evidence of linkage to other regions of the genome in our previous analyses, we attempted to analyze the data as a quantitative trait using MAPMAKER/QTL. However, the combining of raw data from the two sets of animals analyzed with different assays precluded this effort. Analysis of the two sets of progeny separately using MAPMAKER/QTL yielded no evidence of modifying loci, separate from the locus on chromosome 11, to account for the partial penetrance of the phenotype (data not shown). Incomplete penetrance in these assays may derive from one or more unidentified modifier loci, or from experimental variation of the in vitro techniques.
DISCUSSION
Regulation of CD4+ T-cell responses influences several aspects of host immunity, including resistance to pathogens, development of atopic and allergic states, and autoimmune tissue destruction (7, 20, 21) . CD4+ T cells affect such diverse outcomes through production of regulatory cytokines, with Thl and Th2 type cells representing highly polarized patterns of cytokine production. Several factors can influence the development of Thl and Th2 responses. Particular emphasis has been placed on the direct regulatory roles of cytokines, principally IL-4 and IL-12, antigen dose and co-stimulatory molecules (22) . In addition, genetic factors can profoundly influence the Thl/Th2 balance (14) . Because (17) . Some of the markers used are indicated to the left, omitting the "DllMit" prefix. The maximum likelihood position of Tpml, indicated by the shaded bar between DllMitlll (and associated markers) and DllMit274 (and associated markers), is supported by a lod score of 6.5. The 95% confidence interval of Tpml [as defined by a drop in lod of . 1.6 (19) ] is between DllMitl89 and DllMit350, as indicated by the unshaded portions of the bar. Several genes with known or potential influence on Th cell differentiation and located within 2 cM of DllMitlll are listed alphabetically in the box shown to the right. Precise genetic order is not implied. GM-CSF, granulocyte-monocyte colony-stimulating factor; IRF-1, interferon regulatory factor-i; ITK, IL-2-inducible T-cell kinase; Tcf1, T-cell factor 1.
responsible loci controlling differential Thl/Th2 responses between B10.D2 and BALB/c mice.
Our analysis has focused on CD4+ T-cell development under neutral in vitro conditions, in which B10.D2 T cells acquire a more Thl-like phenotype compared with BALB/c T cells and are able to maintain responsiveness to In vitro analysis of a single immune compartment (i.e., CD4+ T cell) is advantageous in the identification of controlling loci, in that it excludes the potentially confounding contributions of other factors participating in complex immune responses in vivo. This approach therefore would not identify all loci that may participate in a particular in vivo response, such as resistance to L. major, but allows identification of loci that regulate a component of the immune response, in this case Thl/Th2 development. This study shows that a single dominant, genetic locus from the B10.D2 background confers the maintenance of IL-12 responsiveness to CD4+ T cells in vitro, thereby favoring Thl development under neutral conditions. In BC1 mice derived from an experimental backcross (BALB/c x F1), one-half of the mice retained the F1 phenotype, indicating the existence of one controlling genetic locus. SSLP mapping analysis using two different assays for IL-12 responsiveness mapped the controlling locus, named here Tpml, to the middle of chromosome 11, a genomic region containing numerous candidate genes of immunologic importance (23, 24) (Fig. 5) .
The syntenic human genomic region 5q31.1 contains the IL-4/IL-5 gene cluster and was shown recently to be linked to high serum IgE levels and airway hyperresponsiveness (8) (9) (10) . Expression of atopy, the result of environmental and genetic factors, is not inherited as a simple Mendelian trait (6, 25) . A common feature of various atopic conditions, however, is the expression of elevated levels of Th2 cytokines (26, 27) . directly induces IgE isotype switching, sensitizes mast cells for antigen-mediated degranulation, and is a mast cell growth factor. IL-5 powerfully induces eosinophil growth, influx, and degranulation. The BALB/c strain exhibits a greater expression of markers of the Th2 phenotype than does the (BlO.D2 related) C57BL/6 strain. For example, BALB/c mice produce higher serum IgE levels (28, 29) , and develop greater antigeninduced airway hyperreactivity (30 (36) . More extensive mapping studies of in vivo L. major susceptibility are needed to confirm this genomic region as a resistance modifier.
The Thi/Th2 balance influences the expression of certain autoimmune disorders. In the murine non-obese diabetic mouse model, several genetic loci contribute to generate an autoimmune T-cell dependent destruction of the islet 3-cell (37) , which can be mediated by Thl but not by Th2 cells (21) . Interestingly, one of the non-obese diabetic loci, idd4, maps to a large region of chromosome 11 (37) . In a transgenic model of autoimmune diabetes, the B1O.D2 background conferred Thl cytokine profiles and susceptibility to diabetes, whereas the BALB/c background conferred Th2 cytokine profiles and disease resistance (38) . Experimental allergic encephalomyelitis, a mouse model of the human demyelinating disease multiple sclerosis, is mediated by a Thl dependent autoimmune process in the central nervous system (39, 40) . Recent analysis of backcrosses between high and low responder inbred mouse strains identified the middle portion of chromosome 11 (peak x2 at IL4) as a potent modifier of disease severity (41) . In the context of distinct genetic and environmental settings, therefore, allelic variants of Tpml may contribute to several immunologically mediated pathological states, including pathogen susceptibility, atopy, and autoimmunity.
The region of mouse chromosome 11 identified in this study contains genes for several cytokines that may influence Thl/ Th2 development (Fig. 5) . IL-4 is an obvious candidate, because it directly promotes Th2 development from naive T cells (1, 4) and antagonizes the action of IL-12 (1, 2 
